ELECSYS T3
Report
- Report Number
- 1823260-2019-03981
- Event Type
- Malfunction
- Date Received
- November 5, 2019
- Date of Event
- October 5, 2019
- Report Date
- January 7, 2020
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- CDP
- PMA / PMN Number
- K962508
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
ADDITIONAL T3 RESULTS FOR THE SAMPLES WERE PROVIDED. PATIENT ID (B)(6): COBAS E801=344 NG/DL, COBAS E601=177.9 NG/DL. PATIENT ID (B)(6): COBAS E801=605 NG/DL, COBAS E601=248 NG/DL. PATIENT ID (B)(6): COBAS E801=407 NG/DL, COBAS E601=184.3 NG/DL. SAMPLES FROM THE PATIENTS WERE SUBMITTED FOR INVESTIGATION. INITIAL INVESTIGATION OF THE SAMPLES CONFIRMED THEY CONTAINED AN IMMUNOGLOBULIN THAT REACTS WITH THE REAGENT AND AFFECTS THE SAMPLE RESULTS. FURTHER TESTING FOUND AN INTERFERING FACTOR AGAINST STREPTAVIDIN COULD BE IDENTIFIED IN THE SAMPLE FOR PATIENT ID (B)(6). THESE INTERFERENCES ARE DOCUMENTED IN PRODUCT LABELING FOR THE ASSAY AS "IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN."
THE INVESTIGATION IS CURRENTLY ONGOING. THE EVENT OCCURRED IN: (B)(6).
THE INITIAL REPORTER COMPLAINED OF QUESTIONABLE ELECSYS T3 RESULTS FOR 4 PATIENTS TESTED ON A COBAS 8000 E 801 MODULE COMPARED TO A COBAS 6000 E 601 MODULE. FROM THE DATA PROVIDED, 3 PATIENTS HAD QUESTIONABLE RESULTS. THE COBAS E601 RESULTS WERE DEEMED CORRECT. THE CUSTOMER STATED THAT FOR ONE UNSPECIFIED PATIENT, THE DATA WAS REPORTED OUTSIDE OF THE LABORATORY BUT A CORRECTED REPORT WAS ISSUED. THE CUSTOMER ONLY PROVIDED THE SERIAL NUMBER FOR 1 COBAS E801, SERIAL NUMBER (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1074244 | ELECSYS T3 | RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE | CDP | ROCHE DIAGNOSTICS | NA | 40680200 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |